A synthetic peptide for use as a blocking control in assays to test for specificity of ACADVL antibody, Alternative Names: ACADVL control peptide, ACADVL antibody Blocking Peptide, Anti-ACADVL Blocking Peptide, acyl-Coenzyme A dehydrogenase, very long chain Blocking Peptide, ACAD6 Blocking Peptide, LCACD Blocking Peptide, VLCAD Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
ACADVL
(Acyl-CoA Dehydrogenase, Very Long Chain (ACADVL))
Synonyme
ACAD6 Peptide, LCACD Peptide, VLCAD Peptide, vlcad Peptide, fb52d04 Peptide, wu:fb52d04 Peptide, wu:fc75e01 Peptide, zgc:64067 Peptide, acyl-CoA dehydrogenase very long chain Peptide, acyl-Coenzyme A dehydrogenase, very long chain Peptide, acyl-CoA dehydrogenase, very long chain Peptide, ACADVL Peptide, Acadvl Peptide, acadvl Peptide
Hintergrund
ACADVL is targeted to the inner mitochondrial membrane where it catalyzes the first step of the mitochondrial fatty acid beta-oxidation pathway. This acyl-Coenzyme A dehydrogenase is specific to long-chain and very-long-chain fatty acids. A deficiency in ACADVL protein reduces myocardial fatty acid beta-oxidation and is associated with cardiomyopathy.